Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]

Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]

Bibliographic Details
Main Authors: Xiaosheng Wu, Yanli Li, Xin Liu, Chunhua Chen, Susan M. Harrington, Siyu Cao, Tiancheng Xie, Tu Pham, Aaron S. Mansfield, Yiyi Yan, Eugene D. Kwon, Liewei Wang, Kun Ling, Haidong Dong
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:Heliyon
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844019321991
id doaj-b9d5013a4fb94e94b8365246538943d0
record_format Article
spelling doaj-b9d5013a4fb94e94b8365246538943d02020-11-25T02:54:55ZengElsevierHeliyon2405-84402019-03-0153e01309Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]Xiaosheng Wu0Yanli Li1Xin Liu2Chunhua Chen3Susan M. Harrington4Siyu Cao5Tiancheng Xie6Tu Pham7Aaron S. Mansfield8Yiyi Yan9Eugene D. Kwon10Liewei Wang11Kun Ling12Haidong Dong13Department of Medicine Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USADivision of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USADivision of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA; Corresponding author.http://www.sciencedirect.com/science/article/pii/S2405844019321991
collection DOAJ
language English
format Article
sources DOAJ
author Xiaosheng Wu
Yanli Li
Xin Liu
Chunhua Chen
Susan M. Harrington
Siyu Cao
Tiancheng Xie
Tu Pham
Aaron S. Mansfield
Yiyi Yan
Eugene D. Kwon
Liewei Wang
Kun Ling
Haidong Dong
spellingShingle Xiaosheng Wu
Yanli Li
Xin Liu
Chunhua Chen
Susan M. Harrington
Siyu Cao
Tiancheng Xie
Tu Pham
Aaron S. Mansfield
Yiyi Yan
Eugene D. Kwon
Liewei Wang
Kun Ling
Haidong Dong
Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]
Heliyon
author_facet Xiaosheng Wu
Yanli Li
Xin Liu
Chunhua Chen
Susan M. Harrington
Siyu Cao
Tiancheng Xie
Tu Pham
Aaron S. Mansfield
Yiyi Yan
Eugene D. Kwon
Liewei Wang
Kun Ling
Haidong Dong
author_sort Xiaosheng Wu
title Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]
title_short Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]
title_full Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]
title_fullStr Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]
title_full_unstemmed Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]
title_sort corrigendum to “targeting b7-h1 (pd-l1) sensitizes cancer cells to chemotherapy” [heliyon 4 (12) (december 2018) e01039]
publisher Elsevier
series Heliyon
issn 2405-8440
publishDate 2019-03-01
url http://www.sciencedirect.com/science/article/pii/S2405844019321991
work_keys_str_mv AT xiaoshengwu corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
AT yanlili corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
AT xinliu corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
AT chunhuachen corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
AT susanmharrington corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
AT siyucao corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
AT tianchengxie corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
AT tupham corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
AT aaronsmansfield corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
AT yiyiyan corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
AT eugenedkwon corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
AT lieweiwang corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
AT kunling corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
AT haidongdong corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039
_version_ 1724718934419046400

Similar Items